(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SHERO DIAGNOSTICS REDEFINING PRECISION MEDICINE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

SHERO DIAGNOSTICS REDEFINING PRECISION MEDICINE

ST13

US500000097639383

Class

5, 9

Filing

97639383

Registration

7930993

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

09/03/2025

Classification

Registered

Trademark type

Combined

Nice classes

5, 9

Filing date

10/19/2022

Registration date

09/02/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/02/2025

Last transaction

09/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/06/2022

First use in commerce

10/06/2022

Drawing code

5

Owner type

03

Owner location

San Jose, CA

Examiner

BERLIN, JUSTIN

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "shero diagnostics redefining precision medicine" arranged in 3 equally long lines as follows: the stylized term "shero" appearing on top in all lower-case letters; the letter "s" is in orange color, and the remaining letters are in grey color. Below the stylized term "shero", the stylized term "diagnostics" appears in all lower-case letters; the second letter "i" of the term "diagnostics" is in orange color; the remaining letters are in black color. Below the stylized term "diagnostics", the stylized wording "redefining precision medicine" appears in black color, all lower-case letters. For each of the three lines, the size of the font and the letters' spacing are such that the wording in each line stretches to occupy the entire length of the image. A thin grey line appears between lines 2 and 3.

Holders and representatives

Holders

S. D. (pessoa física)

Representatives

Shero Diagnostics

Technical classification

Nice Classes

Class 5Class 9

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical diagnostic reagents and assays for testing body fluids for microorganisms

Class 9

Flow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for scientificlaboratorygeneral research uses

Publications

History of USPTO decisions and trademark events.

35 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

09/02/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/13/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/13/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/09/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/09/2025

EX3G

SOU EXTENSION 3 GRANTED

06/09/2025

IUAF

USE AMENDMENT FILED

06/06/2025

EISU

TEAS STATEMENT OF USE RECEIVED

06/06/2025

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

06/06/2025

NREV

NOTICE OF REVIVAL - E-MAILED

06/06/2025

PETG

PETITION TO REVIVE-GRANTED

06/06/2025

PROA

TEAS PETITION TO REVIVE RECEIVED

06/06/2025

EXT3

SOU EXTENSION 3 FILED

05/07/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/26/2024

EX2G

SOU EXTENSION 2 GRANTED

11/26/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/26/2024

EXT2

SOU EXTENSION 2 FILED

11/05/2024

EEXT

SOU TEAS EXTENSION RECEIVED

11/05/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/27/2024

EX1G

SOU EXTENSION 1 GRANTED

04/26/2024

EXT1

SOU EXTENSION 1 FILED

04/26/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/26/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/07/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/12/2023

PUBO

PUBLISHED FOR OPPOSITION

09/12/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/23/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/04/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

08/04/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

08/04/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

08/04/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

08/04/2023

DOCK

ASSIGNED TO EXAMINER

08/02/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/03/2022

NWAP

NEW APPLICATION ENTERED

10/22/2022

Continuous trademark protection

Get notified about every new filing that threatens SHERO DIAGNOSTICS REDEFINING PRECISION MEDICINE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.